{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T09:29:30Z","timestamp":1785403770616,"version":"3.56.0"},"posted":{"date-parts":[[2026,3,3]]},"group-title":"Cancer Biology","reference-count":72,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"award":["F\/2020\/1440"],"award-info":[{"award-number":["F\/2020\/1440"]}],"id":[{"id":"https:\/\/ror.org\/01h3dr788","id-type":"ROR","asserted-by":"publisher"}]},{"award":["ATE-2022\/1863"],"award-info":[{"award-number":["ATE-2022\/1863"]}],"id":[{"id":"https:\/\/ror.org\/01h3dr788","id-type":"ROR","asserted-by":"publisher"}]},{"award":["F\/2024\/2556"],"award-info":[{"award-number":["F\/2024\/2556"]}],"id":[{"id":"https:\/\/ror.org\/01h3dr788","id-type":"ROR","asserted-by":"publisher"}]},{"award":["A5\/5-CQ\/135"],"award-info":[{"award-number":["A5\/5-CQ\/135"]}],"id":[{"id":"https:\/\/ror.org\/03q83t159","id-type":"ROR","asserted-by":"publisher"}]},{"award":["M4\/1\/2\/5-MIS\/BEJ"],"award-info":[{"award-number":["M4\/1\/2\/5-MIS\/BEJ"]}],"id":[{"id":"https:\/\/ror.org\/03q83t159","id-type":"ROR","asserted-by":"publisher"}]},{"award":["A4\/5-MCF\/DEA-CR27"],"award-info":[{"award-number":["A4\/5-MCF\/DEA-CR27"]}],"id":[{"id":"https:\/\/ror.org\/03q83t159","id-type":"ROR","asserted-by":"publisher"}]},{"award":["A4\/5-CR179"],"award-info":[{"award-number":["A4\/5-CR179"]}],"id":[{"id":"https:\/\/ror.org\/03q83t159","id-type":"ROR","asserted-by":"publisher"}]},{"award":["Yound Investigator Award to NvG"],"award-info":[{"award-number":["Yound Investigator Award to NvG"]}],"id":[{"id":"https:\/\/ror.org\/038ja4880","id-type":"ROR","asserted-by":"publisher"}]},{"award":["2022\/14232\/ZONMW"],"award-info":[{"award-number":["2022\/14232\/ZONMW"]}],"id":[{"id":"https:\/\/ror.org\/01yaj9a77","id-type":"ROR","asserted-by":"publisher"}]},{"award":["1R01DK075850-01"],"award-info":[{"award-number":["1R01DK075850-01"]}],"id":[{"id":"https:\/\/ror.org\/01cwqze88","id-type":"ROR","asserted-by":"publisher"}]},{"award":["1R01CA160458-01A"],"award-info":[{"award-number":["1R01CA160458-01A"]}],"id":[{"id":"https:\/\/ror.org\/01cwqze88","id-type":"ROR","asserted-by":"publisher"}]},{"award":["Scholar Award to AAL"],"award-info":[{"award-number":["Scholar Award to AAL"]}],"id":[{"id":"https:\/\/ror.org\/04m0xav37","id-type":"ROR","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016394","name":"Ludwig Center at Harvard","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100016394","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Baillet Latour Fund"},{"id":[{"id":"https:\/\/ror.org\/04kj1hn59","id-type":"ROR","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016394","name":"Ludwig Center at Harvard","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100016394","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,3,3]]},"abstract":"<jats:title>Summary<\/jats:title>\n                <jats:p>\n                  Though cancer cells\u2019 altered metabolism has been recognized for a century, the clinical success of metabolic targeting remains limited due to metabolic plasticity. Here, we use acute myeloid leukemia (AML) as a model to investigate this adaptability through combinatorial metabolic compound screening. Synthetic lethality emerged when AML cells were simultaneously treated with a glutaminase inhibitor and TOFA, a hypolipidemic agent. Sensitivity to this combination was also seen in primary patient samples and in other cancer types, while healthy hematopoietic progenitors were not affected. Unexpectedly, we discovered that TOFA acts through a non-canonical inhibition of protein\n                  <jats:italic>S<\/jats:italic>\n                  -acyltransferases. Protein\n                  <jats:italic>S<\/jats:italic>\n                  -acylation in AML cells specifically requires 16-to-18 carbon long fatty acids and is essential to maintain mitochondrial respiration upon glutaminolysis inhibition. Healthy cells in contrast have high intrinsic metabolic flexibility independent of\n                  <jats:italic>S<\/jats:italic>\n                  -acylation. Our results expose a unique mechanism of metabolic plasticity in cancer that could be targeted to enhance metabolic anti-cancer therapies.\n                <\/jats:p>","DOI":"10.64898\/2026.03.02.708949","type":"posted-content","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T06:25:11Z","timestamp":1772605511000},"source":"Crossref","is-referenced-by-count":0,"title":["Protein\n                  <i>S<\/i>\n                  -acylation dynamics provide metabolic plasticity to acute myeloid leukemia cells"],"prefix":"10.64898","author":[{"given":"Nithya","family":"Balasundaram","sequence":"first","affiliation":[{"name":"Cellular Metabolism and Microenvironment Laboratory, de Duve Institute, UCLouvain, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ay\u015feg\u00fcl","family":"Erdem","sequence":"additional","affiliation":[{"name":"Cellular Metabolism and Microenvironment Laboratory, de Duve Institute, UCLouvain, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azeem","family":"Sharda","sequence":"additional","affiliation":[{"name":"Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA"},{"name":"Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA, USA"},{"name":"Harvard Stem Cell Institute, Cambridge, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veerle W.","family":"Daniels","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip L.","family":"Chea","sequence":"additional","affiliation":[{"name":"Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fleur","family":"Leguay","sequence":"additional","affiliation":[{"name":"Cellular Metabolism and Microenvironment Laboratory, de Duve Institute, UCLouvain, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youzhong","family":"Liu","sequence":"additional","affiliation":[{"name":"Cellular Metabolism and Microenvironment Laboratory, de Duve Institute, UCLouvain, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Keibler","sequence":"additional","affiliation":[{"name":"Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA"},{"name":"Alnylam Pharmaceuticals, Cambridge, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Vidoudez","sequence":"additional","affiliation":[{"name":"Harvard Center for Mass Spectrometry, Harvard University, Cambridge, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew A.","family":"Lane","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Vertommen","sequence":"additional","affiliation":[{"name":"MASSPROT platform, de Duve Institute, UCLouvain, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Casteur","sequence":"additional","affiliation":[{"name":"Imelda Hospital, Bonheiden, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u00ebl R.","family":"Laurent","sequence":"additional","affiliation":[{"name":"Imelda Hospital, Bonheiden, Belgium"},{"name":"Centre for Metabolic Bone Diseases, University Hospitals Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunia A.","family":"Trauger","sequence":"additional","affiliation":[{"name":"Harvard Center for Mass Spectrometry, Harvard University, Cambridge, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Stephanopoulos","sequence":"additional","affiliation":[{"name":"Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9821-7133","authenticated-orcid":false,"given":"David T.","family":"Scadden","sequence":"additional","affiliation":[{"name":"Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA"},{"name":"Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA, USA"},{"name":"Harvard Stem Cell Institute, Cambridge, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0563-3590","authenticated-orcid":false,"given":"Nick","family":"van Gastel","sequence":"additional","affiliation":[{"name":"Cellular Metabolism and Microenvironment Laboratory, de Duve Institute, UCLouvain, Brussels, Belgium"},{"name":"WELBIO Department, WEL Research Institute, Wavre, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2026030616001003000_2026.03.02.708949v1.1","unstructured":"SEER *Explorer: An interactive website for SEER cancer statistics [Internet]. Surveillance Research Program, National Cancer Institute; 2025 Apr 16. [cited 2026 Januari 26]. Available from: https:\/\/seer.cancer.gov\/statistics-network\/explorer\/."},{"key":"2026030616001003000_2026.03.02.708949v1.2","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-023-01424-6"},{"key":"2026030616001003000_2026.03.02.708949v1.3","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00425-3"},{"key":"2026030616001003000_2026.03.02.708949v1.4","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.molmed.2020.10.001","article-title":"Extinguishing the Embers: Targeting AML Metabolism","volume":"27","year":"2021","journal-title":"Trends Mol Med"},{"key":"2026030616001003000_2026.03.02.708949v1.5","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-021-01416-w"},{"key":"2026030616001003000_2026.03.02.708949v1.6","doi-asserted-by":"publisher","DOI":"10.1016\/J.TCB.2022.11.004"},{"key":"2026030616001003000_2026.03.02.708949v1.7","doi-asserted-by":"crossref","first-page":"104710","DOI":"10.1016\/j.exphem.2025.104710","article-title":"Serum NMR metabolomics in distinct subtypes of hematologic malignancies","volume":"143","year":"2025","journal-title":"Exp Hematol"},{"key":"2026030616001003000_2026.03.02.708949v1.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2011.10.015"},{"key":"2026030616001003000_2026.03.02.708949v1.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2012.12.013"},{"key":"2026030616001003000_2026.03.02.708949v1.10","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-02103-8"},{"key":"2026030616001003000_2026.03.02.708949v1.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2017.09.007"},{"key":"2026030616001003000_2026.03.02.708949v1.12","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-01-621870"},{"key":"2026030616001003000_2026.03.02.708949v1.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2018.10.005"},{"key":"2026030616001003000_2026.03.02.708949v1.14","doi-asserted-by":"publisher","DOI":"10.1172\/JCI38942"},{"key":"2026030616001003000_2026.03.02.708949v1.15","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/s43018-020-00126-z","article-title":"Fatty acid metabolism underlies venetoclax resistance in acute myeloid leukemia stem cells","volume":"1","year":"2020","journal-title":"Nat Cancer"},{"key":"2026030616001003000_2026.03.02.708949v1.16","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-20-0844"},{"key":"2026030616001003000_2026.03.02.708949v1.17","doi-asserted-by":"crossref","first-page":"100730","DOI":"10.1016\/j.drup.2020.100730","article-title":"Ex vivo cultures and drug testing of primary acute myeloid leukemia samples: Current techniques and implications for experimental design and outcome","volume":"53","year":"2020","journal-title":"Drug Resist Updat"},{"key":"2026030616001003000_2026.03.02.708949v1.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2020.10.010"},{"key":"2026030616001003000_2026.03.02.708949v1.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.01.042"},{"key":"2026030616001003000_2026.03.02.708949v1.20","doi-asserted-by":"publisher","DOI":"10.1021\/jm301191p"},{"key":"2026030616001003000_2026.03.02.708949v1.21","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)86677-2"},{"key":"2026030616001003000_2026.03.02.708949v1.22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31963-4"},{"key":"2026030616001003000_2026.03.02.708949v1.23","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.2239"},{"key":"2026030616001003000_2026.03.02.708949v1.24","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-3871"},{"key":"2026030616001003000_2026.03.02.708949v1.25","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-023-02664-7"},{"key":"2026030616001003000_2026.03.02.708949v1.26","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-3223"},{"key":"2026030616001003000_2026.03.02.708949v1.27","doi-asserted-by":"publisher","DOI":"10.1007\/s10495-007-0718-8"},{"key":"2026030616001003000_2026.03.02.708949v1.28","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-008-8030-5"},{"key":"2026030616001003000_2026.03.02.708949v1.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ab.2004.01.020"},{"key":"2026030616001003000_2026.03.02.708949v1.30","doi-asserted-by":"publisher","DOI":"10.1093\/NAR\/GKAA1025"},{"key":"2026030616001003000_2026.03.02.708949v1.31","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-024-00763-x"},{"key":"2026030616001003000_2026.03.02.708949v1.32","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1038\/s41375-024-02390-9","article-title":"Stearoyl-CoA desaturase inhibition is toxic to acute myeloid leukemia displaying high levels of the de novo fatty acid biosynthesis and desaturation","volume":"38","year":"2024","journal-title":"Leukemia"},{"key":"2026030616001003000_2026.03.02.708949v1.33","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-22-0411"},{"key":"2026030616001003000_2026.03.02.708949v1.34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0033823"},{"key":"2026030616001003000_2026.03.02.708949v1.35","doi-asserted-by":"publisher","DOI":"10.1038\/nrm.2017.107"},{"key":"2026030616001003000_2026.03.02.708949v1.36","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-024-00700-8"},{"key":"2026030616001003000_2026.03.02.708949v1.37","doi-asserted-by":"publisher","DOI":"10.1007\/BF02562334"},{"key":"2026030616001003000_2026.03.02.708949v1.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpa.2021.07.002"},{"key":"2026030616001003000_2026.03.02.708949v1.39","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1007\/s11427-021-2048-2","article-title":"Palmitoylation of MDH2 by ZDHHC18 activates mitochondrial respiration and accelerates ovarian cancer growth","volume":"65","year":"2022","journal-title":"Sci China Life Sci"},{"key":"2026030616001003000_2026.03.02.708949v1.40","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022019056"},{"key":"2026030616001003000_2026.03.02.708949v1.41","doi-asserted-by":"publisher","DOI":"10.1007\/BF01504608"},{"key":"2026030616001003000_2026.03.02.708949v1.42","doi-asserted-by":"publisher","DOI":"10.1038\/S41573-021-00339-6"},{"key":"2026030616001003000_2026.03.02.708949v1.43","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-023-00971-9"},{"key":"2026030616001003000_2026.03.02.708949v1.44","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15965"},{"key":"2026030616001003000_2026.03.02.708949v1.45","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1038\/s43018-024-00811-3","article-title":"Glutaminase inhibition in combination with azacytidine in myelodysplastic syndromes: a phase 1b\/2 clinical trial and correlative analyses","volume":"5","year":"2024","journal-title":"Nat Cancer"},{"key":"2026030616001003000_2026.03.02.708949v1.46","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1001\/jamaoncol.2022.3511","article-title":"Efficacy and Safety of Telaglenastat Plus Cabozantinib vs Placebo Plus Cabozantinib in Patients With Advanced Renal Cell Carcinoma: The CANTATA Randomized Clinical Trial","volume":"8","year":"2022","journal-title":"JAMA Oncol"},{"key":"2026030616001003000_2026.03.02.708949v1.47","doi-asserted-by":"crossref","first-page":"1124678","DOI":"10.3389\/fnut.2023.1124678","article-title":"A metabolic shift toward glycolysis enables cancer cells to maintain survival upon concomitant glutamine deprivation and V-ATPase inhibition","volume":"10","year":"2023","journal-title":"Front Nutr"},{"key":"2026030616001003000_2026.03.02.708949v1.48","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s42255-020-0195-8","article-title":"Identifying strategies to target the metabolic flexibility of tumours","volume":"2","year":"2020","journal-title":"Nat Metab"},{"key":"2026030616001003000_2026.03.02.708949v1.49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28737-3"},{"key":"2026030616001003000_2026.03.02.708949v1.50","doi-asserted-by":"crossref","first-page":"216696","DOI":"10.1016\/j.canlet.2024.216696","article-title":"Palmitoylation alters LDHA activity and pancreatic cancer response to chemotherapy","volume":"587","year":"2024","journal-title":"Cancer Lett"},{"key":"2026030616001003000_2026.03.02.708949v1.51","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26180-4"},{"key":"2026030616001003000_2026.03.02.708949v1.52","first-page":"e2412895","article-title":"Palmitic Acid Accelerates Endothelial Cell Injury and Cardiovascular Dysfunction via Palmitoylation of PKM2","volume":"12","year":"2025","journal-title":"Adv Sci (Weinh"},{"key":"2026030616001003000_2026.03.02.708949v1.53","doi-asserted-by":"publisher","DOI":"10.1021\/bi0508082"},{"key":"2026030616001003000_2026.03.02.708949v1.54","doi-asserted-by":"publisher","DOI":"10.1016\/j.devcel.2022.02.019"},{"key":"2026030616001003000_2026.03.02.708949v1.55","doi-asserted-by":"publisher","DOI":"10.1105\/tpc.012500"},{"key":"2026030616001003000_2026.03.02.708949v1.56","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1038\/s42255-024-01121-9","article-title":"Organization of a functional glycolytic metabolon on mitochondria for metabolic efficiency","volume":"6","year":"2024","journal-title":"Nat Metab"},{"key":"2026030616001003000_2026.03.02.708949v1.57","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2004.11.014"},{"key":"2026030616001003000_2026.03.02.708949v1.58","doi-asserted-by":"publisher","DOI":"10.1096\/fj.07-9199com"},{"key":"2026030616001003000_2026.03.02.708949v1.59","doi-asserted-by":"publisher","DOI":"10.1021\/jm00216a009"},{"key":"2026030616001003000_2026.03.02.708949v1.60","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2016.08.014"},{"key":"2026030616001003000_2026.03.02.708949v1.61","doi-asserted-by":"crossref","first-page":"e141529","DOI":"10.1172\/JCI141529","article-title":"Stabilization of fatty acid synthesis enzyme acetyl-CoA carboxylase 1 suppresses acute myeloid leukemia development","volume":"131","year":"2021","journal-title":"J Clin Invest"},{"key":"2026030616001003000_2026.03.02.708949v1.62","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2016.89"},{"key":"2026030616001003000_2026.03.02.708949v1.63","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkae253"},{"key":"2026030616001003000_2026.03.02.708949v1.64","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkw377"},{"key":"2026030616001003000_2026.03.02.708949v1.65","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymben.2006.09.001"},{"key":"2026030616001003000_2026.03.02.708949v1.66","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkad1045"},{"key":"2026030616001003000_2026.03.02.708949v1.67","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkae1011"},{"key":"2026030616001003000_2026.03.02.708949v1.68","doi-asserted-by":"crossref","first-page":"100461","DOI":"10.1016\/j.xpro.2021.100461","article-title":"Dynamic BH3 profiling method for rapid identification of active therapy in BH3 mimetics resistant xenograft mouse models","volume":"2","year":"2021","journal-title":"STAR Protoc"},{"key":"2026030616001003000_2026.03.02.708949v1.69","first-page":"E667","article-title":"Isotopomer spectral analysis of triglyceride fatty acid synthesis in 3T3-L1 cells","volume":"263","year":"1992","journal-title":"Am J Physiol"},{"key":"2026030616001003000_2026.03.02.708949v1.70","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-416618-9.00019-4"},{"key":"2026030616001003000_2026.03.02.708949v1.71","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2007.225"},{"key":"2026030616001003000_2026.03.02.708949v1.72","doi-asserted-by":"crossref","unstructured":"Tewari, R. , West, S.J. , Shayahati, B. , and Akimzhanov, A.M . (2020). Detection of Protein S-Acylation using Acyl-Resin Assisted Capture. J Vis Exp.","DOI":"10.3791\/61016"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.03.02.708949","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:00:23Z","timestamp":1772841623000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.64898\/2026.03.02.708949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,3]]},"references-count":72,"URL":"https:\/\/doi.org\/10.64898\/2026.03.02.708949","relation":{},"subject":[],"published":{"date-parts":[[2026,3,3]]},"subtype":"preprint"}}